Karyopharm Therapeutics | KPTI - Eigenkapital Und Reserven

Aktienkurs
8.00
Täglich Wechseln
-0.16 -1.96%
Monatlich
-8.57%
Jährlich
86.48%
Q2 Prognose
7.78




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Abbott USD 52.13B 1.3B 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Incyte USD 5.17B 516.28M 2025-12
J&J USD 78.47B 0 2025-09
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Merck USD 51.85B 2.79B 2025-09
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Takeda JPY 7.64T 513.39B 2025-12
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Xencor USD 635.59M 10.27M 2025-12